Sackler, Purdue Pharma and opioid crisis

Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
Sacklers, Purdue To Pay $7.4 Bn Over Opioid Crisis: NY State
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
Sackler family and Purdue agree to pay Utah $57 million for opioid damages
Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families."
Purdue Pharma, Sackler Family To Pay $7.4 Billion In Settlement Over OxyContin That Fueled 'Devastating' Opioid Epidemic
The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication OxyContin accountable for their role in the opioid crisis.
Purdue Pharma To Pay $7.4B In Historic Opioid Settlement: How Much Will NY Get?
Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed hundreds of thousands of Americans.The Sackler family and Purdue Pharma reached a $7.
Massachusetts to receive more than $100 million from landmark opioid settlement with Purdue Pharma, Sacklers
The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have protected members of the wealthy Sackler family from civil lawsuits over OxyContin.
Montana to receive $16M from Purdue opioid settlement
Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 billion settlement with attorneys general from a coalition of states.
Purdue Pharma to pay TN, other states billions for role in opioid crisis
The settlement payout will be delivered “directly” to communities over the next 15 years to support opioid addiction treatment, prevention and recovery programs, according to a press
Sackler family, Purdue Pharma agree to pay $7.4B to settle opioid suit by 15 states
The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.
The Independent5d
Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands
If approved, Purdue Pharma will contribute $900 million ... and played a critical role in starting and fueling the opioid epidemic,” James said in a press release. “While no amount of money ...
The News Journal5d
Delaware slated to receive over $27M in settlement with Purdue Pharma, Sackler family
Purdue Pharma and the Sackler family will pay $7.4 billion for their role in the opioid epidemic. Delaware will receive over $27 million from the settlement. The settlement comes just shy of a ...
Settlement with Sackler family may offer Utah vital funds to combat drug overdose epidemic
The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...